Levoamphetamine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLevoamphetamine
Drug Alias NameL-alpha-methylphenethylamineL-amfetamineL-amphetamineLevamfetamine(-)-Amphetamine +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonistsCentral nervous system stimulants
TargetsAdrenergic receptors
Therapy Area/IndicationsCognition DisordersMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBrown University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCognition Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsCognition DisordersMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksWikipedia